Wednesday, November 26, 2014
YOLO COUNTY NEWS
99 CENTS

Sickle cell drug shows promise in UCD trial

By
From page A8 | July 06, 2014 |

A UC Davis clinical trial has found safe a drug designed to treat a common, painful complication of sickle cell disease.

There are currently no specific treatments for vaso-occlusive crises, during which clumped-together blood cells hinder blood flow. It is responsible for more than 70,000 hospitalizations annually, according to Ted Wun, associate dean for research at the UCD School of Medicine.

The 15-patient trial found no severe side-effects from the drug, dubbed GMI 1070, and that it was maintaining adequate concentrations in the blood.

Published online in the journal Public Library of Science ONE, the study was not aimed at determining the drug’s effectiveness, but Wun said it did show small improvements in blood flow and reduced the markers of cell activation.

Sickle cell disease, which lowers life expectancy by 20 to 30 years, affects an estimated 90,000 to 100,000 Americans, mostly blacks, according to the U.S. Centers for Disease Control and Prevention.

It is caused by abnormal hemoglobin that contorts red blood cells into a sickle shape, making them stiff and sticky. These clumped cells reduce blood flow, leading to severe hip, back and long-bone pain, and, often, chest and abdominal pain.

“White blood cells bind to inflamed blood vessel walls and sickle red cells stick to white cells, but interestingly the initiating event is the white cells,” Wun said in a news release. “If we could interrupt that white cell interaction, we could stop the cycle that leads to vaso-occlusions.”

The new drug is designed to do that by mimicking sugars attached to cell-adhesion proteins, called selectins, reducing the stickiness and increasing blood flow.

Sickle cell most often strikes the kidneys, lungs and spleen, but it can affect any organ. Stroke, infections, hypertension and heart failure are among its severe complications.

Patients in the trial tolerated the drug well, with headaches the most common side-effect. Preliminary results of a second trial also have been positive, and have been submitted for publication, according to researchers. A third phase is planned.

“If the phase III study confirms that GMI 1070 is effective, it would be a huge advance for the sickle cell community,” Wun said.

GlycoMimetics Inc., a Maryland-based biotechnology company based in Gaithersburg, produces the new drug under the trade name Rivipansel. The company paid for the trial.

Also this week, National Institutes of Health scientists announced the results of a study that found bone marrow transplants can reverse sickle cell disease. The transplant worked in 26 of 30 adults, and 15 of them were even able to stop taking drugs that prevent rejection one year later.

The treatment is a modified version of bone marrow transplants that have worked in children. Donors are a brother or sister whose stem cell-rich bone marrow is a good match for the patient.

The treatment involves using chemotherapy and radiation to destroy bone marrow before replacing it with healthy donor marrow cells.

Results from the adult study, involving patients aged 29 on average, were published in the Journal of the American Medical Association.

—The Associated Press contributed to this report.

Comments

comments

Cory Golden

Cory Golden

The Enterprise's higher-education and congressional reporter. http://about.me/cory_golden
  • Recent Posts

  • Enter your email address to subscribe to this newspaper and receive notifications of new articles by email.

  • .

    News

    Time to give thanks for nature’s beauty

    By Enterprise staff | From Page: A1 | Gallery

     
    Food fight … in a good way

    By Tanya Perez | From Page: A1 | Gallery

    Fremont Weir parking lot remains closed

    By Elizabeth Case | From Page: A1

     
    Occupy movement settles in at UC Davis

    By Tanya Perez | From Page: A1 | Gallery

    Guard reinforcements contain damage in Ferguson

    By The Associated Press | From Page: A2 | Gallery

     
    Weather affecting Thanksgiving travelers

    By The Associated Press | From Page: A2 | Gallery

     
    Happy Thanksgiving from The Enterprise

    By Enterprise staff | From Page: A3

    Free bike clinic, ride set Sunday

    By Enterprise staff | From Page: A3

     
    Year-end films to see, or not, on KDRT

    By Enterprise staff | From Page: A3 | Gallery

     
    LCI marks 50 years with special service

    By Enterprise staff | From Page: A3

    Pedal around Davis on weekly bike ride

    By Enterprise staff | From Page: A3

     
    Senior Center hosts holiday sing-along

    By Enterprise staff | From Page: A4

    Sutter sponsors qigong for holiday de-stress

    By Enterprise staff | From Page: A4

     
    Learn to use Skype at Connections Café

    By Enterprise staff | From Page: A4

    Girls who volunteer may apply for grant

    By Enterprise staff | From Page: A4

     
    Round up at the registers for Davis schools

    By Enterprise staff | From Page: A4

    Davis Community Gift Project brightens holidays for children

    By Anne Ternus-Bellamy | From Page: A4

     
    Speaker proposes changes in humanities doctorate

    By Special to The Enterprise | From Page: A4 | Gallery

    Boy Scouts start Christmas tree sales on Friday

    By Enterprise staff | From Page: A5

     
    Volunteers needed to grow plants for habitat restoration

    By Special to The Enterprise | From Page: A5 | Gallery

    Rainbow City community meeting set Dec. 1

    By Special to The Enterprise | From Page: A12

     
    .

    Forum

    She wants more from him

    By Creators Syndicate | From Page: B5

     
    Innovation parks comparison

    By Letters to the Editor | From Page: A6

    Tom Meyer cartoon

    By Debbie Davis | From Page: A6

     
    Musings in the wake of Ferguson decision

    By Special to The Enterprise | From Page: A6

    Planting love at new home

    By Letters to the Editor | From Page: A6

     
    .

    Sports

    Let’s not lose another good DHS coach

    By Chris Saur | From Page: B1

     
    Blue Devils prepare for a new season on the mat

    By Evan Ream | From Page: B1 | Gallery

    No excuses, but there’s hope for UCD after 2-9 season

    By Bruce Gallaudet | From Page: B1

     
    Joseph, Manzanares lead 10 All-Big Sky Aggie picks

    By Bruce Gallaudet | From Page: B1 | Gallery

    DHS wrestling is not just for boys

    By Evan Ream | From Page: B1 | Gallery

     
    Davis Little League offers early sign-up discounts

    By Enterprise staff | From Page: B2

     
    Kings get past Pelicans

    By The Associated Press | From Page: B6

    .

    Features

    Salute to non-steamed broccoli

    By Dan Kennedy | From Page: A7 | Gallery

     
    .

    Arts

    It really is ‘The Best Christmas Pageant Ever’

    By Debra DeAngelo | From Page: A11 | Gallery

     
    .

    Business

    .

    Obituaries

    Elzyne Thompson

    By Special to The Enterprise | From Page: A4

     
    Death notice: Buddy Ralph Mills

    By Special to The Enterprise | From Page: A4

    .

    Comics

    Comics: Wednesday, November 26, 2014

    By Creator | From Page: A9

     
    .

    Ready, Set, Shop!

    Shop locally: You can have your pie and eat it too

    By Enterprise staff | From Page: RSS1

    Santa’s little helper: secrets to happy holiday shopping

    By San Francisco Chronicle | From Page: RSS2

    Make sure it gets there: deadlines for shopping and shipping

    By The Associated Press | From Page: RSS2

    Downtown lights up at holiday open house

    By Enterprise staff | From Page: RSS3

    Full of warm wishes and over-sharing, the holiday card lives on

    By The Associated Press | From Page: RSS4

    Shop smart: Protect your wallet and your identity this shopping season

    By Special to The Enterprise | From Page: RSS5

    Woodland celebrates the holidays downtown

    By Special to The Enterprise | From Page: RSS5